Phenylalanine hydroxylase genotypes, predicted residual enzyme activity and phenotypic parameters of diagnosis and treatment of phenylketonuria.
The interdependence of the predicted in vitro residual enzyme activity (PRA), as deduced from the complete genotypes of 64 hyperphenylalaninaemic patients, and parameters for diagnosis of hyperphenylalaninaemic disorders, the fluctuation of the phyenlylalanine (Phe) values during treatment, long-term dietary control during treatment, and a parameter for the outcome of therapy (IQ) was investigated by correlation analysis. A highly significant correlation was found between the PRA and diagnostic parameters, as well as the fluctuation of the Phe values during treatment. Significant correlations were also observed between the parameter describing the fluctuation of the Phe values and the IQ, as well as between the quality of dietary control and IQ. The PRA is a valuable tool for the differential diagnosis of hyperphenylalaninaemic disorders and for the prediction of one aspect of the course of the disease which is related to the intellectual outcome of therapy. The quality of dietary control was independent of the genotype, indicating that the outcome of therapy can be successfully manipulated in spite of the genetic make-up.
Burgard
P
P
Department of General Pediatrics, University of Heidelberg, Germany.
Rupp
A
A
Konecki
D S
DS
Trefz
F K
FK
Schmidt
H
H
Lichter-Konecki
U
U
D000483:Alleles; D004789:Enzyme Activation; D005838:Genotype; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D010651:Phenylalanine Hydroxylase / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D010661:Phenylketonurias / Q000175:diagnosis / Q000178:diet therapy / Q000235:genetics*
D010651:Phenylalanine Hydroxylase